FDA

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.

Scholars offer approaches to improve regulation of social media marketing.

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.

As the alternative meat industry takes off, regulation will confront a new frontier.

As fecal microbiota transplantation gains traction in the medical world, regulators may need to step in.

Scholars propose to modify the current regulatory regime for animal-based medical diagnostics.

Current testing practices in the pharmaceutical industry exploit social and racial inequities.

FDA should increase its regulatory oversight of tattoo ink safety.

CMS reconsiders a recent Medicare premium increase after restricting coverage for a controversial new drug.

FDA proposes a new rule to permit the purchase of hearing aids without a prescription.

Experts discuss regulatory options for PFAS chemical contamination control.